Mazur Leonard L — SEC insider filings

SEC reporting owner CIK 1463414. 21 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2020-10-09 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Tharimmune, Inc. (THAR)Director41 leg · 25,000 sh · $100,000—5
Citius Pharmaceuticals, Inc. (CTXR)Chief Executive Officer, Director10——16
CITIUS ONCOLOGY, INC. (CTOR)Chief Executive Officer, Director7——7

Insider filings — Mazur Leonard L

FiledFormIssuerReported transactionsSource
2026-11-124CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-12-224/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,700,000 @ $0EDGAR
2025-12-014/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,700,000 @ $0EDGAR
2025-09-234Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 125,490 (derivative) · Grant/award (A): 125,490 (derivative) · Disposition to issuer (D): 89,388 (derivative) · Grant/award (A): 89,388 (derivative)EDGAR
2025-09-234CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,700,000 @ $0EDGAR
2024-12-164CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 800,000 (derivative) @ $0EDGAR
2024-11-124Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 600,000 (derivative) @ $0EDGAR
2024-09-274Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 3,137,255 (derivative) · Grant/award (A): 3,137,255 (derivative) · Disposition to issuer (D): 2,234,700 (derivative) · Grant/award (A): 2,234,700 (derivative)EDGAR
2024-08-304/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 3,700,000 (derivative) @ $0EDGAR
2024-08-144CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 1,233,333 (derivative) @ $0EDGAR
2024-08-124Tharimmune, Inc. (THAR)Grant/award (A): 2,353 (derivative) @ $0EDGAR
2024-04-054Citius Pharmaceuticals, Inc. (CTXR)Disposition to issuer (D): 1,165,048 (derivative) · Grant/award (A): 1,165,048 (derivative)EDGAR
2023-11-094Tharimmune, Inc. (THAR)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-10-124Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 550,000 (derivative) @ $0EDGAR
2022-11-154/ACitius Pharmaceuticals, Inc. (CTXR)Holdings only — no transactions reportedEDGAR
2022-10-064Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 550,000 (derivative) @ $0EDGAR
2022-03-234Hillstream BioPharma Inc. (HILS)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2022-01-184Hillstream BioPharma Inc. (HILS)Conversion (C): 98,733 @ $3.20 · Purchase (P): 25,000 @ $4 · Conversion (C) @ $0EDGAR
2021-10-134Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 650,000 (derivative) @ $0EDGAR
2021-07-264Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2020-10-094Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1463414 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs